Are you eligible for Fedorov Therapy?
What is the probability of positively responding to our treatment and having noticeable improvements in your eyesight?
Our treatment is recommended for patients suffering from any optic nerve atrophy but especially damage originating as glaucomatous, ischemic, traumatic, inflammatory, post tumor, or hydrocephalus induced optic neuropathies. Our treatment has also proven successful in cases of underdeveloped optic nerves (hypoplasia). Patients with certain types of retinal diseases including inherited dystrophies like retinitis pigmentosa and cone dystrophies have measurable benefits from this treatment as well.
Conducted in Germany between 2007-2012 several double blind, placebo controlled, and randomized clinical trials have established the efficacy of Fedorov Restoration Therapy scientifically and clinically validating this treatment modality. Routine clinical use in both Russia (1991 - present) and Germany (2007 - present) has demonstrated safety of this electrical stimulation without side effects or worsening vision.
Our vision restoration clinic in Berlin (Germany) was founded to fill the gap between ophthalmology and neurology to help improve functional eyesight in visually impaired patients due to optic nerve damage or retinal dystrophies. Our therapy was established between 1995-1999 based on brain stimulation research dating back to 1980-1988 in Russia. Although this treatment is relatively new outside of Europe, we have successfully helped many patients improve their eyesight and regain their independence since 1995. We have treated more than 10,000 patients with Fedorov Restoration Therapy with over 70% of them have reported a higher quality of life.
We do not claim that everyone may benefit from our treatment. Qualification for Fedorov Restoration Therapy is granted if we expect a reasonable probability that the patient will positively respond to the treatment and experience subsequent functional visual benefits. In case of very severe or nearly complete optic nerve or retina atrophy patients are not eligible in any case. Additionally, we evaluate all potential contraindications to ensure our therapy is safe. If you are unsure if your patient is a good candidate, feel free to reach out to us and we would be glad to answer your questions.